BioWorld

Sep. 5, 2007

View Archived Issues

J. Craig Venter Institute Publishes J. Craig Venter Genome Sequence

Clinical Data's Vilazodone Positive In Phase III Study

GNI Gains New Listing In Japan Raises $7.7M For Drug Discovery

Anacor Seeks $57.5M In IPO For Topical Boron-Based Pipeline

Other News To Note

Clinic Roundup

NeurogesX Reports Positive Phase III Study Of NGX-4010

NeurogesX Inc. reported the pain patch NGX-4010 met primary and secondary endpoints in a third Phase III trial, and the second in patients with postherpetic neuralgia. (BioWorld Today) Read More

Acambis Smallpox Vaccine Finally Wins U.S. Approval

Today's news in brief

BioWorld

BioWorld briefs for June 17, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for June 17, 2025.

Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA

BioWorld

During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...

23andme founder-led group outbids Regeneron for company

BioWorld

The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...

Elevidys’ second liver death hits Sarepta, sends DMD ripples

BioWorld

How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...